Comparison of remimazolam + flumazenil antagonization and propofol on emergence time in patients who undergo awake craniotomy: a randomized comparative study
Not Applicable
Recruiting
- Conditions
- brain tumor
- Registration Number
- JPRN-UMIN000041355
- Lead Sponsor
- Sapporo Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 126
Inclusion Criteria
Not provided
Exclusion Criteria
Patient who has allergy for propofol, remimazolam and flumazenil Patient who has severe hepatic and/or renal dynfunction Patient who determined as inappropriate for enrollment by the researcher of this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method